Skip to main content

Determinants of Cardiac Myosin Binding Protein C in the General Population

Tracking # 20-1298117

Price not reported

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Broadcasted Interactive Event
Dates Contact provider

Course overview

The webinar will present our article using data from a population-based Norwegian age cohort study of more than 3700 individuals, assessing potential determinants of cardiac myosin binding protein C (cMyC). We identify demographic and clinical determinants of cMyC and investigate the relationship between imaging signs of structural myocardial disease and cMyC in the presumably healthy, general population. Our work is an early step in utilizing concentrations of this novel cardiac biomarker to identify individuals in the general population who are at increased risk of cardiovascular disease. By participating in the webinar, we hope you will join in considering the implications of our results and evaluate the use of cardiac myosin binding protein C in cardiovascular risk assessment of the general population.

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

1h Category 1

Molecular Diagnostics Diplomate

1h Category 1

Toxicological Chemistry Diplomate

1h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

1h General

Clinical Laboratory Supervisor

1h General

Clinical Laboratory Technician

1h General

Clinical Laboratory Technologist

1h General

Public Health Director

1h General

Public Health Supervisor

1h General

Public Health Technologist

1h General

Disclosure statements

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.


The following faculty reported financial relationships:

  • Michael Paus, MD
  • Honorarium/Expenses: Abbott Diagnostics


The following faculty reported no financial relationships:

  • Ian Young, MD, FRCP, FRCPath